Why Every AI Lab Will Become a Biotech Company | Andrew Huberman

Patrick O'Shaughnessy sits down with neuroscientist and podcaster Andrew Huberman. They dive deep into the physiological secrets of high performers, exploring how founders can manage their energy, downshift after stressful days, and optimize sleep using science-backed tools like non-sleep deep rest (NSDR) and physiological sighs. Huberman also shares his candid thoughts on the current "theatrics" of the public health and longevity space. Finally, they explore the wild frontier of neurotechnology, discussing the massive implications of reading and writing to the brain non-invasively, why AI giants are actually biotech companies, and the ethical realities of genetic engineering. Whether you want to optimize your daily focus or understand the cyborg future of human-computer interaction, this episode delivers. Timestamps: 0:00 Intro 1:00 Building Energy for High Performance 7:00 How to Fall Asleep 18:10 What’s Gone Wrong With Health Optimization 24:10 AI Companies Could Become Biotech Companies 30:45 Implantable Devices 33:45 Memory 42:50 Controlling Your Brain 59:00 Genetic Engineering 1:11:05 The Key to Meaningful Success #AndrewHuberman #Neuroscience #Biohacking #SleepOptimization #Neurotech #Longevity #HealthAndWellness #InvestLikeTheBest #MentalPerformance #ArtificialIntelligence Presented by Ramp: https://ramp.com/invest Sponsored by Vanta, WorkOS, Rogo, and Ridgeline: https://www.vanta.com/invest https://workos.com/ https://rogo.ai/invest https://www.ridgelineapps.com/ ****** Patrick O'Shaughnessy is the CEO of Positive Sum. All opinions expressed by Patrick and podcast guests are solely their own and do not reflect the opinion of Positive Sum. This podcast is for informational purposes only and should not be relied upon as a basis for investment decisions. Clients of Positive Sum may maintain positions in the securities discussed in this podcast. To learn more, visit psum.vc

GPT-4正在为你翻译摘要中......

翻译全文